Angiotensin Receptor Blockers in Chronic Heart Failure: Clinical Implications and Molecular Mechanisms

Publisher： Bentham Science Publishers

E-ISSN： 1875-6557|3|4|296-303

ISSN： 1573-403X

Source： Current Cardiology Reviews, Vol.3, Iss.4, 2007-11, pp. : 296-303

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Endothelial dysfunction in chronic heart failure: clinical and therapeutic implications

By Adamopoulos S.   Parissis J.T.   Kremastinos D.T.  

European Journal of Internal Medicine, Vol. 13, Iss. 4, 2002-06 ,pp. : 233-239

Elsevier

Access to resources Recommend Favorite

Beta-blockers for chronic heart failure: surviving longer but feeling better?

By Bolger A.P.   Al-Nasser F.  

International Journal of Cardiology, Vol. 92, Iss. 1, 2003-11 ,pp. : 1-8

Elsevier

Access to resources Recommend Favorite

TRANSCEND Aftermath: Angiotensin II Type 1 Receptor Antagonists (Angiotensin Receptor Blockers) at the Clinical Crossroad

By Volpe Massimo  

High Blood Pressure & Cardiovascular Prevention, Vol. 16, Iss. 1, 2009-05 ,pp. : 1-6

Adis International

Access to resources Recommend Favorite

Angiotensin II, sympathetic nerve activity and chronic heart failure

By Wang Yutang   Seto Sai-Wang   Golledge Jonathan  

Heart Failure Reviews, Vol. 19, Iss. 2, 2014-03 ,pp. : 187-198

Springer Publishing Company

Access to resources Recommend Favorite

The Renin-Angiotensin System: The Role of Inhibitors, Blockers, and Genetic Polymorphisms in the Treatment and Prevention of Heart Failure

By  

Current Vascular Pharmacology, Vol. 1, Iss. 1, 2003-03 ,pp. : 33-39

Bentham Science Publishers

Access to resources Recommend Favorite